ALNYLAM PHARMACEUTICALS INC
For the period ended May 16, 2024. Filed Apr 1, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 16, 2024 · Filed Apr 1, 2024
Contents
PROXY STATEMENT SUMMARY
This summary highlights important information you will find in this Proxy Statement. As it is only a summary, please review the complete Proxy Statement before you vote.
Virtual Annual Meeting Information
| Date: | Thursday, May 16, 2024 |
|---|---|
| Time: | 10:30 a.m., Eastern Time |
| Location: | Online at www.virtualshareholdermeeting.com/ALNY2024 |
| You will not be able to attend the annual meeting in person. | |
| Record Date: | March 22, 2024 |
Voting Items and Board Recommendations
| Board Recommendation | ||
| Proposal 1 | Election of Four (4) Class II Directors | FOR All Nominees |
|---|---|---|
| Proposal 2 | Say-on-Pay—Advisory Vote on Approval of Executive Compensation | FOR |
| Proposal 3 | Ratification of Independent Auditors | FOR |
All proxies will be voted in accordance with the instructions contained in those proxies. If no choice is specified, the proxies will be voted in favor of the matters set forth in the accompanying Notice of Meeting. On any other matters properly brought before the annual meeting, the named proxies may vote in accordance with their best judgment.
Page | 1
How to Vote
| Vote Right Away Through Advance Voting Methods | Vote During Meeting | ||
|---|---|---|---|
| Vote by Internet Using Your Computer | Vote by Telephone | Vote by Mail | Vote During the Meeting |
| Go to www.proxyvote.com and enter the 16-digit control number provided on your proxy card or voting instruction form. | Call 1-800-690-6903 or the number on your proxy card or voting instruction form. You will need the 16-digit control number provided on your proxy card or voting instruction form. | If you received printed proxy materials, complete, sign and date the proxy card or voting instruction form and mail it in the accompanying pre-addressed envelope. | See “Important Information About the Annual Meeting and Voting – Voting” for details on how to vote during the Annual Meeting. |
Important Notice Regarding the Internet Availability of Proxy Materials for
the Annual Meeting of Stockholders to be Held on May 16, 2024
We are furnishing proxy materials to our stockholders primarily via the Internet. On or about April 3, 2024, we will mail to our stockholders a Notice of Internet Availability containing instructions on how to access our proxy materials, including this Proxy Statement, our Annual Report on Form 10-K and our Annual Report to Stockholders. The Notice of Internet Availability also instructs you on how to submit your proxy or voting instructions through the Internet or to request a paper copy of our proxy materials, including a proxy card or voting instruction form that includes instructions on how to submit your proxy or voting instructions by mail or telephone. Other stockholders, in accordance with their prior requests, have receivede-mail access to our proxy materials and instructions to submit their vote via the Internet, or have been mailed paper copies of our proxy materials and a proxy card or voting instruction form.
This Proxy Statement, our Annual Report on Form 10-K and our Annual Report to Stockholders are available for viewing, printing and downloading atwww.proxyvote.com.
A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the Securities and Exchange Commission, or SEC, on February 15, 2024, will be furnished without charge to any stockholder upon written request to Alnylam Pharmaceuticals, Inc., 675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts 02142, Attention: Investor Relations and Corporate Communications.
This Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are also available on the SEC’s website atwww.sec.gov.
Page | 2
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.